Authors:
Itoh, S
Nonoyama, S
Morio, T
Imai, K
Okawa, H
Ochs, HD
Shimadzu, M
Yata, J
Citation: S. Itoh et al., Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia, INT J HEMAT, 71(1), 2000, pp. 79-83
Authors:
Imai, K
Nonoyama, S
Miki, H
Morio, T
Fukami, K
Zhu, QL
Aruffo, A
Ochs, HD
Yata, J
Takenawa, T
Citation: K. Imai et al., The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton, CLIN IMMUNO, 92(2), 1999, pp. 128-137
Authors:
Morio, T
Hanissian, SH
Bacharier, LB
Teraoka, H
Nonoyama, S
Seki, M
Kondo, J
Nakano, H
Lee, SK
Geha, RS
Yata, J
Citation: T. Morio et al., Ku in the cytoplasm associates with CD40 in human B cells and translocatesinto the nucleus following incubation with IL-4 and anti-CD40 mAb, IMMUNITY, 11(3), 1999, pp. 339-348
Authors:
Iwata, S
Sato, Y
Asada, M
Takagi, M
Tsujimoto, A
Inaba, T
Yamada, T
Sakamoto, S
Yata, J
Shimogori, T
Igarashi, K
Mizutani, S
Citation: S. Iwata et al., Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation, ONCOGENE, 18(1), 1999, pp. 165-172
Authors:
Nagasawa, M
Hirai, K
Mizutani, S
Okawa, H
Yata, J
Citation: M. Nagasawa et al., EBV infection induced transformation of benign T lymphoproliferative statein patient with chronic active EBV infection into malignant lymphoma: implication of EBV infection as additive oncogenic factor in tumorigenesis, LEUK RES, 23(11), 1999, pp. 1071-1078
Authors:
Baba, Y
Nonoyama, S
Matsushita, M
Yamadori, T
Hashimoto, S
Imai, K
Arai, S
Kunikata, T
Kurimoto, M
Kurosaki, T
Ochs, HD
Yata, J
Kishimoto, T
Tsukada, S
Citation: Y. Baba et al., Involvement of Wiskott-Aldrich syndrome protein in B-Cell cytoplasmic tyrosine kinase pathway, BLOOD, 93(6), 1999, pp. 2003-2012